NSPR logo

InspireMD Stock Price

Symbol: NasdaqCM:NSPRMarket Cap: US$99.7mCategory: Healthcare

NSPR Share Price Performance

US$2.42
-0.44 (-15.38%)
US$2.42
-0.44 (-15.38%)
Price US$2.42

NSPR Community Narratives

There are no narratives available yet.

Recent NSPR News & Updates

No updates

InspireMD, Inc. Key Details

US$7.1m

Revenue

US$5.6m

Cost of Revenue

US$1.5m

Gross Profit

US$42.9m

Other Expenses

-US$41.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.99
Gross Margin
21.06%
Net Profit Margin
-585.64%
Debt/Equity Ratio
0%

InspireMD, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About NSPR

Founded
2005
Employees
66
CEO
Marvin Slosman
WebsiteView website
www.inspiremd.com

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard neuroprotection system for transcarotid access and neuro protection, as well as treating acute stroke with tandem lesions. It has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Miami, Florida.

U.S. Market Performance

  • 7 Days: 2.3%
  • 3 Months: 12.9%
  • 1 Year: 20.2%
  • Year to Date: 8.3%
The market has climbed 2.3% in the last 7 days, lead by the Information Technology sector with a gain of 4.1%. In the last year, the market has climbed 20%. Earnings are forecast to grow by 15% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading